newsfilter
← Latest News
GlobeNewswire·

Avalo Reports 2024 Financial Results and Recent Business Updates

Topline data from Phase 2 LOTUS Trial of AVTX-009 for the treatment of hidradenitis suppurativa expected in 2026 Appointed Jennifer Riley as Chief Strategy Officer Cash on hand of approximately $135 million as of